Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary sclerosing cholangitis: a progressive disease?

M K Porayko1, N F LaRusso, R H Wiesner

  • 1Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota 55905.

Seminars in Liver Disease
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interactions between chronic liver disease and inflammatory bowel disease.

Inflammatory bowel diseases·2013
Same author

A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation.

Kidney international·2007
Same author

Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism.

American journal of physiology. Gastrointestinal and liver physiology·2007
Same author

Biliary tract physiology.

Current opinion in gastroenterology·2006
Same author

Biliary tract physiology.

Current opinion in gastroenterology·2006
Same author

Membrane microdomains in hepatocytes: potential target areas for proteins involved in canalicular bile secretion.

Journal of lipid research·2005

Primary Sclerosing Cholangitis (PSC) often progresses to liver failure over time, with variable rates of advancement. Early diagnosis and long-term follow-up are crucial for understanding disease progression and patient outcomes.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Primary Sclerosing Cholangitis (PSC) is a chronic liver disease with variable progression.
  • Early diagnosis of PSC is increasingly common due to advancements in ERCP and routine liver tests.
  • Understanding the natural history of PSC is essential for patient management.

Purpose of the Study:

  • To review the natural history and progression of Primary Sclerosing Cholangitis.
  • To highlight the importance of long-term follow-up in PSC patients.
  • To identify challenges in predicting disease progression and liver failure in PSC.

Main Methods:

  • Review of existing literature on Primary Sclerosing Cholangitis.
  • Analysis of survival data and disease progression patterns.

Related Experiment Videos

  • Discussion of statistical survival modeling approaches.

    • Main Results:

    • PSC frequently progresses to liver failure over extended periods.
    • Disease progression can occur asymptomatically.
    • Earlier diagnosis has led to improved survival estimates.
    • Predicting individual disease trajectory remains a challenge.

    Conclusions:

    • Long-term prospective follow-up is vital for observing PSC progression and mortality.
    • Accurate prediction of disease progression and liver failure timing is a future challenge.
    • Statistical models require further refinement for clinical application in PSC management.